Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
114 * !
|
Mon, 7/29/2019,
8:30 AM -
10:20 AM
|
CC-108
|
|
Applying the ICH E9(R1) Addendum: Practical Considerations in Choosing Estimands, Estimators, and Sensitivity Analyzes — Topic Contributed Papers
|
|
Biopharmaceutical Section, ENAR, WNAR
|
|
Organizer(s): Pilar Lim, PhD, Janssen Research & Development, LLC
|
|
Chair(s): Pilar Lim, PhD, Janssen Research & Development, LLC
|
|
8:35 AM
|
Descending from the Theoretical to the Practical: Our Journey from Clear Definition to Messy Inference and Back
Michael O'Kelly, IQVIA
|
|
8:55 AM
|
How Should We Select and Define Trial Estimands? – Examples Based on a Disease State
Elena Polverejan, Johnson & Johnson-Janssen R&D
|
|
9:15 AM
|
Implementation of Estimand Framework in Oncology Clinical Trials
Kalyanee Appanna, Novartis Pharmaceutical Corporation; Bharani Dharan, Novartis Pharmaceuticals; Yuanbo Song, Novartis Pharmaceutical Corporation; Ekkehard Glimm, Novartis Pharma AG
|
|
9:35 AM
|
Lessons Learned from Implementing ICH E9 in Phase 2 Trials Across Multiple Therapeutic Areas
Jared Christensen, Pfizer Research
|
|
9:55 AM
|
Discussant: Craig Mallinckrodt, PhD, Biogen
|
|
10:15 AM
|
Floor Discussion
|
|
